Condron 400 hard capsules
Spain
Table of Contents
Package leaflet: Information for the user
Introduction
PACKAGE LEAFLET: INFORMATION FOR THE USER
Condrodin 400 mg hard capsules
Chondroitin sodium sulfate
Read the entire leaflet carefully before you start taking this medicine.
- Keep this leaflet as you may need to read it again.
- If you have any questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only and must not be given to other people, even if they have the same symptoms as you, because it could harm them.
- If you experience any adverse reactions not listed in this leaflet, see section 4.
Leaflet contents
- What Condrodin is and what it is used for
- What you need to know before taking Condrodin
- How to take Condrodin
- Possible side effects
- How to store Condrodin
- Contents of the pack and other information
1. What Condrodin is and what it is used for
Condrodin belongs to the group of other non-steroidal anti-inflammatory and anti-rheumatic agents.
This medicine is used for the symptomatic treatment of osteoarthritis.
2. What you need to know before starting to take Condrodin
Do not take Condrodin
- If you are allergic (hypersensitive) to chondroitin sulfate or to any of the other ingredients of this medicine.
Warnings and precautions
Talk to your doctor or pharmacist before starting to take this medicine.
- Be cautious if you have a severe kidney, liver, or heart disease.
Other medicines and Condrodin
Inform your doctor or pharmacist if you are taking, have recently taken, or might need to take any other medicines.
Administration of chondroitin sulfate at doses much higher than recommended, together with antiplatelet agents used to prevent thrombosis, such as acetylsalicylic acid, dipyridamole, clopidogrel, dithiazole, triflusal, and ticlopidine, may slightly increase the effect of the aforementioned medicines.
Taking Condrodin with food and drink
You may take this medicine before, during, or after meals. However, if you often experience stomach discomfort when taking medicines, it is advisable to take Condrodin after meals.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to become pregnant, consult your doctor or pharmacist before using this medicine. It is unknown whether chondroitin sulfate passes into breast milk. Therefore, do not take this medicine during breastfeeding, as there are insufficient data on the effect this medicine may have on the health of the breastfed infant.
Consult your doctor or pharmacist before using any medicine.
Driving and using machines
Condrodin is not expected to affect your ability to drive vehicles or operate machinery.
Condrodin contains sodium
- Patients on low-sodium diets should be aware that this medicine contains 36.40 mg (1.58 mmol) of sodium per capsule.
3. How to take Condrodin
Follow exactly the instructions for use of this medicine as given by your doctor. If you have any doubts, consult your doctor or pharmacist.
The recommended dose for adult patients is 2 capsules (total daily dose: 800 mg of chondroitin sulfate) per day, preferably taken as a single dose (2 capsules at once) for at least 3 months. However, if considered appropriate by the physician, treatment may be initiated with a dose of 1,200 mg (3 capsules per day, either as a single dose or divided into two doses) for the first 4 to 6 weeks, followed by 800 mg (2 capsules per day, preferably as a single dose) until completing a treatment period of at least 3 months.
Treatment should be administered for a minimum of 3 months. After this period, a 2-month treatment-free interval may be considered due to the drug's residual effect, after which treatment may be restarted following the same cycle.
The capsules should be taken without chewing. They may be taken before, during, or after meals.
Use in children and adolescents: The use of this medicine is not recommended in children and adolescents under 18 years of age due to the lack of data on safety and efficacy.
If you take more Condrodin than you should
If you have taken more Condrodin than you should, you are unlikely to experience any symptoms. Nevertheless, you should inform your doctor or pharmacist.
If you forget to take Condrodin
Do not take a double dose to make up for forgotten doses.
If you stop taking Condrodin
Symptoms may reappear.
If you have any further questions about the use of this product, ask your doctor or pharmacist.
4. Possible adverse effects
Like all medicines, this medicine may cause adverse effects, although not everyone experiences them.
In rare cases (may affect up to 1 in 1,000 patients), nausea and/or gastrointestinal disturbances have been reported, which generally do not require discontinuation of treatment.
In very rare cases (may affect 1 in 10,000 patients), cases of edema and/or fluid retention have been described.
In very rare cases (may affect 1 in 10,000 patients), allergic-type reactions have been reported.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is an adverse effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Medicines: www.notificaRAM.es. By reporting adverse effects, you can help provide more information on the safety of this medicine.
5. Storage of Condrodin
Keep in the original packaging to protect it from moisture.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date refers to the last day of the month indicated.
Medicines must not be disposed of via wastewater drains or household waste. Dispose of empty containers and unused medicines at the SIGRE collection point at your pharmacy. If you are unsure, ask your pharmacist how to properly dispose of unused containers and medicines. This will help protect the environment.
6. Package contents and other information
Composition of Condrodin
- The active substance is chondroitin sulfate. Each capsule contains 400 mg of sodium chondroitin sulfate.
- The other component is magnesium stearate. Capsule composition: gelatin, titanium dioxide, quinoline yellow (E-104), indigotine (E-132).
Appearance of the medicine and contents of the pack
This medicine is presented as hard gelatin capsules. Each pack contains 60 hard capsules in blister packs.
Marketing Authorization Holder and Manufacturer
Marketing Authorization Holder:
LABORATORIO REIG JOFRE, S.A.
Gran Capitán, 10
08970 Sant Joan Despí (Barcelona), Spain.
Manufacturer:
NOUCOR HEALTH., S.A.
Avda. Camí Reial, 51-57
08184 Palau-solità i Plegamans (Barcelona) - Spain
Date of the most recent revision of this leaflet: September 2022
Detailed information on this medicine is available on the website of the Spanish Medicines Agency: http://www.aemps.gob.es